Eton Pharmaceuticals

Contributing Author

Recent Articles by Eton Pharmaceuticals

Mar-03	Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026 ETON GlobeNewswire
Mar-02	Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL (propranolol hydrochloride) Oral Solution ETON +6.83% GlobeNewswire
Feb-25	Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution ETON GlobeNewswire
Feb-20	Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th ETON GlobeNewswire
Feb-02	Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate ETON GlobeNewswire
Nov-24	Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th ETON GlobeNewswire
Nov-12	Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th ETON GlobeNewswire
Nov-06	Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results ETON -11.70% ETON GlobeNewswire
Oct-23	Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 ETON GlobeNewswire
Aug-20	Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference ETON GlobeNewswire
Aug-07	Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results ETON +12.32% ETON GlobeNewswire
Jul-28	Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 ETON GlobeNewswire
Jul-08	Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) ETON +9.80% GlobeNewswire
Jun-27	Eton Pharmaceuticals Announces Addition to Russell 2000 and Russell 3000 Indexes ETON GlobeNewswire
May-28	Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI (hydrocortisone) Oral Solution ETON -5.78% ETON GlobeNewswire
May-14	Eton Pharmaceuticals to Participate at Upcoming Investor Conferences ETON +15.07% ETON GlobeNewswire
May-13	Eton Pharmaceuticals Reports First Quarter 2025 Financial Results ETON GlobeNewswire
May-01	Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 ETON GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)